Medicine composition for treating neurodermatitis

A composition and neurological technology, applied in the direction of drug combination, neurological diseases, skin diseases, etc., can solve problems such as no treatment

Inactive Publication Date: 2017-05-31
JINAN HAOYU QINGTIAN PHARMA TECH CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There is no clinically effective method for treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine composition for treating neurodermatitis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Embodiment 1: the pharmaceutical composition for the treatment of neurodermatitis and preparation method thereof

[0033] The composition and parts by weight of the raw material drug of the pharmaceutical composition for treating neurodermatitis are: Potentinic acid 28g, prolactin 1285g, polyalgae 843g;

[0034] Preparation:

[0035] (1) According to the proportion of raw materials, take Potentinic acid, prolactin, polyalgae, mix well, use ethanol with a concentration of 39% by weight as a solvent, and extract by warm soaking at 36.5°C. The number of extractions is 13 times, and the extraction time for each For 1 hour, the amount of solvent each time is 22.5 times the total weight of the raw material drug, filtered to obtain medicinal residue A and extract A, extract A recovered ethanol, concentrated to a relative density of 1.06, filtered, and the drug solution passed through FU-02 The macroporous adsorption resin column is firstly eluted with water, and then the FU-0...

Embodiment 2

[0038] Embodiment 2: the pharmaceutical composition for the treatment of neurodermatitis and preparation method thereof

[0039]The composition and parts by weight of the raw material drug of the pharmaceutical composition for treating neurodermatitis are: 26g of pallinic acid, 1290g of prolactin and 840g of polyalgae;

[0040] Preparation:

[0041] (1) According to the proportion of raw materials, take Potentinic acid, prolactin, polyalgae, mix well, use ethanol with a concentration of 39% by weight as a solvent, and extract by warm soaking at 36.5°C. The number of extractions is 13 times, and the extraction time for each For 1 hour, the amount of solvent each time is 22.5 times the total weight of the raw material drug, filtered to obtain medicinal residue A and extract A, extract A recovered ethanol, concentrated to a relative density of 1.06, filtered, and the drug solution passed through FU-02 The macroporous adsorption resin column is firstly eluted with water, and then...

Embodiment 3

[0044] Embodiment 3: the pharmaceutical composition for the treatment of neurodermatitis and preparation method thereof

[0045] The composition and parts by weight of the raw material drug of the pharmaceutical composition for treating neurodermatitis are: 30g of pallinic acid, 1280g of prolactin and 846g of polyalgae;

[0046] Preparation:

[0047] (1) According to the proportion of raw materials, take Potentinic acid, prolactin, polyalgae, mix well, use ethanol with a concentration of 39% by weight as a solvent, and extract by warm soaking at 36.5°C. The number of extractions is 13 times, and the extraction time for each For 1 hour, the amount of solvent each time is 22.5 times the total weight of the raw material drug, filtered to obtain medicinal residue A and extract A, extract A recovered ethanol, concentrated to a relative density of 1.06, filtered, and the drug solution passed through FU-02 The macroporous adsorption resin column is firstly eluted with water, and the...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicine composition for treating neurodermatitis and a preparation method thereof. The medicine composition is proportionally prepared by using tormentic acid, herbs of heterostemma oblongifolium and herbs of myriophyllum spicatum as active pharmaceutical ingredients. The medicine composition can be prepared into various dosage forms according to a conventional preparation process; the curative effect on treating neurodermatitis is obvious.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, and in particular relates to a pharmaceutical composition for treating neurodermatitis and a preparation method thereof. Background technique [0002] Neurodermatitis is a common chronic skin nerve disorder skin disease, characterized by severe itching and localized lichenification of the skin, and its occurrence is mostly related to nervous system dysfunction, cerebral cortex excitation and inhibition balance imbalance. Neurodermatitis belongs to the category of "itching" syndrome in traditional Chinese medicine. Traditional Chinese medicine believes that the disease is caused by deficiency of liver and kidney yin in the body, stagnation of liver qi, dampness in the spleen, inability to transport and transform water dampness, water dampness staying in the skin, and exogenous dampness and heat. There is no effective method for clinical treatment. [0003] Tormentic acid: C...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/27A61P17/00A61P25/00A61K31/56
CPCA61K36/27A61K31/56A61K36/185A61K2236/333A61K2236/39A61K2236/51A61K2236/55
Inventor 不公告发明人
Owner JINAN HAOYU QINGTIAN PHARMA TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap